Mizuho Maintains Buy on ACADIA Pharmaceuticals, Raises Price Target to $40

ACADIA Pharmaceuticals Inc. +1.12% Pre

ACADIA Pharmaceuticals Inc.

ACAD

17.08

17.08

+1.12%

0.00% Pre

Mizuho analyst Uy Ear maintains ACADIA Pharmaceuticals (NASDAQ: ACAD) with a Buy and raises the price target from $35 to $40.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via